January 7, 2016

Will White House review of biotech regulation lead to expanded or streamlined rules?

From: Genetic Literacy Project

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

The Obama administration recently announced an ambitious White House initiative to update the 30-year-old Coordinated Framework for the regulation of Biotechnology. (Disclosure: the coauthor of this article, John Cohrssen, was legal counsel to the White House working group that developed and implemented the 1986 Coordinated Framework.) The White House has directed the three regulatory agencies with biotechnology oversight — the EPA, FDA, and USDA — to update the Framework and develop a long-term strategy to ensure that the regulatory system is prepared for the future products of biotechnology, using a newly commissioned expert analysis of the biotechnology landscape.

By creating an environment that is friendly to biotechnology and the commercialization of products, the Obama White House has a unique opportunity to reduce the regulatory obstacles to continued U.S. advances in agriculture. . . Clearly, reforms are needed to make regulation scientifically defensible and risk-based, and to ensure that it provides acceptable cost-benefit.

Read Complete Article

No Comments »

No comments yet.

Leave a Reply

Name not required for anonymous comments. Email is optional and will not be published.